Anticholinergic [EPC]

Anticholinergic [EPC] was reported 16280 times

Drugs of the Anticholinergic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 REBOUND PSYCHOSIS 20 0.0939
1 VAGINAL FLATULENCE 21 0.0693
2 TOXIC ANTERIOR SEGMENT SYNDROME 69 0.0632
3 FLOPPY IRIS SYNDROME 23 0.0623
4 CATARACT NUCLEAR 41 0.0615
5 ANTICHOLINERGIC SYNDROME 95 0.0596
6 RETINAL OCCLUSIVE VASCULITIS 13 0.0580
7 NEUROMUSCULAR BLOCKADE 13 0.0580
8 CREATININE RENAL CLEARANCE INCREASED 38 0.0508
9 SECONDARY HYPOGONADISM 16 0.0485
10 CUTIS LAXA 13 0.0478
11 MULTIPLE DRUG THERAPY 36 0.0477
12 HYPOTONY OF EYE 20 0.0476
13 RHYTHM IDIOVENTRICULAR 15 0.0462
14 MONOCYTOSIS 27 0.0435
15 BACTERIAL TRANSLOCATION 13 0.0410
16 NEUROMUSCULAR BLOCK PROLONGED 15 0.0407
17 CATARACT SUBCAPSULAR 21 0.0344
18 BRASH SYNDROME 47 0.0335
19 PALMOPLANTAR PUSTULOSIS 16 0.0302
20 HYPOPYON 25 0.0302
21 DRUG EFFECT PROLONGED 16 0.0290
22 CHOLINERGIC SYNDROME 18 0.0282
23 CORNEAL OEDEMA 62 0.0276
24 CHOROIDAL DETACHMENT 15 0.0270
25 SEDATION COMPLICATION 69 0.0270
26 ANTERIOR CHAMBER CELL 19 0.0266
27 DIABETIC RETINAL OEDEMA 13 0.0256
28 RETINAL ISCHAEMIA 15 0.0245
29 HYPERTHERMIA MALIGNANT 36 0.0242
30 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 21 0.0236
31 PRESSURE OF SPEECH 15 0.0231
32 CHOROIDAL NEOVASCULARISATION 19 0.0221
33 INFLAMMATORY PAIN 15 0.0221
34 VITRITIS 40 0.0216
35 CARDIAC PROCEDURE COMPLICATION 13 0.0214
36 MACULAR FIBROSIS 14 0.0206
37 MITRAL VALVE CALCIFICATION 13 0.0202
38 VASOPLEGIA SYNDROME 33 0.0201
39 INTESTINAL PSEUDO-OBSTRUCTION 17 0.0193
40 PUPIL FIXED 31 0.0179
41 RETINAL DEGENERATION 23 0.0177
42 STOMA SITE PAIN 26 0.0177
43 STRESS CARDIOMYOPATHY 102 0.0175
44 ANGLE CLOSURE GLAUCOMA 44 0.0172
45 ENDOPHTHALMITIS 103 0.0172
46 OCULAR HYPERTENSION 33 0.0170
47 ANOSOGNOSIA 13 0.0169
48 EXPOSURE TO SARS-COV-2 28 0.0165
49 CHOROIDAL EFFUSION 13 0.0162
50 VITREOUS DETACHMENT 35 0.0161
51 SYSTOLIC DYSFUNCTION 17 0.0161
52 ULCERATIVE KERATITIS 44 0.0160
53 DELAYED RECOVERY FROM ANAESTHESIA 15 0.0158
54 NECROTISING COLITIS 20 0.0158
55 CREATININE RENAL CLEARANCE DECREASED 63 0.0157
56 BRADYCARDIA FOETAL 13 0.0156
57 CYSTOID MACULAR OEDEMA 29 0.0154
58 RETINAL EXUDATES 14 0.0150
59 BRONCHIAL SECRETION RETENTION 19 0.0149
60 SINUS ARREST 23 0.0147
61 MYDRIASIS 188 0.0146
62 CHANGE OF BOWEL HABIT 29 0.0141
63 FEMALE GENITAL TRACT FISTULA 24 0.0140
64 CORNEAL OPACITY 19 0.0139
65 PUPILS UNEQUAL 15 0.0131
66 NODAL RHYTHM 19 0.0130
67 SOMATIC SYMPTOM DISORDER 14 0.0130
68 CORNEAL DISORDER 28 0.0128
69 PUPILLARY REFLEX IMPAIRED 23 0.0124
70 OBSTRUCTIVE SLEEP APNOEA SYNDROME 18 0.0123
71 SUBRETINAL FLUID 13 0.0119
72 JUDGEMENT IMPAIRED 17 0.0117
73 SALIVARY HYPERSECRETION 112 0.0112
74 PULSELESS ELECTRICAL ACTIVITY 46 0.0110
75 VITREOUS HAEMORRHAGE 30 0.0108
76 METAMORPHOPSIA 20 0.0108
77 RETINAL DISORDER 28 0.0108
78 HYPERTHERMIA 81 0.0106
79 RENAL FUNCTION TEST ABNORMAL 49 0.0105
80 HIRSUTISM 14 0.0105
81 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 23 0.0105
82 LARYNGOSPASM 28 0.0104
83 ANTIPSYCHOTIC DRUG LEVEL INCREASED 29 0.0103
84 ACCIDENTAL DEATH 19 0.0102
85 LEFT ATRIAL DILATATION 13 0.0102
86 RENAL ARTERY STENOSIS 14 0.0102
87 APLASTIC ANAEMIA 53 0.0101
88 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 26 0.0099
89 WRONG PATIENT RECEIVED PRODUCT 29 0.0099
90 PRODUCT PACKAGING CONFUSION 24 0.0099
91 RADICULOPATHY 26 0.0099
92 ANAESTHETIC COMPLICATION 26 0.0097
93 HYPERAEMIA 19 0.0096
94 CONJUNCTIVAL HYPERAEMIA 34 0.0095
95 SCHIZOAFFECTIVE DISORDER 17 0.0095
96 ANORECTAL DISORDER 19 0.0095
97 APNOEA 73 0.0094
98 VITREOUS FLOATERS 88 0.0089
99 MACULAR OEDEMA 50 0.0089
100 BRADYCARDIA 465 0.0088
101 DIASTOLIC DYSFUNCTION 27 0.0087
102 SINUS BRADYCARDIA 84 0.0087
103 EYE INFLAMMATION 81 0.0085
104 VENTRICULAR FIBRILLATION 94 0.0085
105 OSTEOSCLEROSIS 13 0.0082
106 PULSE ABSENT 39 0.0082
107 IRIDOCYCLITIS 25 0.0079
108 BRADYARRHYTHMIA 13 0.0079
109 PROCTITIS 22 0.0078
110 RETINAL OEDEMA 15 0.0078
111 BLOOD SODIUM INCREASED 21 0.0078
112 MOTION SICKNESS 15 0.0078
113 NEPHROGENIC ANAEMIA 36 0.0078
114 BLOOD CALCIUM DECREASED 87 0.0077
115 CHRONIC SINUSITIS 29 0.0077
116 HAEMODYNAMIC INSTABILITY 58 0.0076
117 COMA SCALE ABNORMAL 22 0.0076
118 RETINAL HAEMORRHAGE 53 0.0074
119 CARDIOGENIC SHOCK 106 0.0074
120 BLOOD CREATININE DECREASED 23 0.0073
121 ATRIOVENTRICULAR BLOCK COMPLETE 49 0.0073
122 BIPOLAR I DISORDER 16 0.0073
123 NEUTROPENIC COLITIS 15 0.0072
124 LEFT VENTRICULAR HYPERTROPHY 31 0.0072
125 HYPERPARATHYROIDISM SECONDARY 18 0.0072
126 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 19 0.0071
127 LONG QT SYNDROME 17 0.0071
128 PRODUCT ADHESION ISSUE 252 0.0070
129 MACULAR DEGENERATION 83 0.0069
130 INTRAOCULAR PRESSURE INCREASED 88 0.0069
131 VENTRICULAR TACHYCARDIA 113 0.0068
132 TEMPERATURE REGULATION DISORDER 15 0.0067
133 ATRIOVENTRICULAR BLOCK FIRST DEGREE 29 0.0067
134 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 22 0.0066
135 AORTIC ARTERIOSCLEROSIS 17 0.0066
136 ACUTE PULMONARY OEDEMA 37 0.0066
137 KERATITIS 20 0.0066
138 CONJUNCTIVAL HAEMORRHAGE 25 0.0065
139 ARTERIOSPASM CORONARY 26 0.0065
140 VENTRICULAR EXTRASYSTOLES 67 0.0064
141 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 33 0.0064
142 ATRIOVENTRICULAR BLOCK SECOND DEGREE 19 0.0063
143 KOUNIS SYNDROME 14 0.0062
144 HYPOVENTILATION 20 0.0061
145 COMPARTMENT SYNDROME 16 0.0061
146 BUNDLE BRANCH BLOCK RIGHT 28 0.0061
147 RETINAL TEAR 15 0.0061
148 ORTHOSTATIC HYPOTENSION 103 0.0059
149 BUNDLE BRANCH BLOCK LEFT 25 0.0059
150 RESPIRATORY ACIDOSIS 23 0.0058
151 TRICUSPID VALVE INCOMPETENCE 46 0.0058
152 UVEITIS 78 0.0057
153 HIGH DENSITY LIPOPROTEIN DECREASED 19 0.0057
154 THERAPEUTIC AGENT TOXICITY 19 0.0057
155 BLEPHARITIS 22 0.0055
156 STRABISMUS 16 0.0054
157 ATELECTASIS 52 0.0054
158 LEFT VENTRICULAR DYSFUNCTION 36 0.0054
159 CREPITATIONS 16 0.0054
160 PLANTAR FASCIITIS 18 0.0054
161 RETINAL DETACHMENT 49 0.0053
162 RESPIRATORY DEPRESSION 65 0.0053
163 VENTRICULAR HYPOKINESIA 17 0.0053
164 MITRAL VALVE INCOMPETENCE 58 0.0051
165 BLOOD PRESSURE SYSTOLIC DECREASED 23 0.0051
166 SEDATION 132 0.0050
167 SUPRAVENTRICULAR EXTRASYSTOLES 17 0.0050
168 SUPRAVENTRICULAR TACHYCARDIA 48 0.0050
169 TROPONIN INCREASED 38 0.0050
170 ACUTE RESPIRATORY FAILURE 96 0.0050
171 SINUS TACHYCARDIA 70 0.0049
172 MULTIPLE INJURIES 31 0.0049
173 AUTONOMIC NERVOUS SYSTEM IMBALANCE 14 0.0048
174 ATRIOVENTRICULAR BLOCK 37 0.0048
175 DERMATITIS ACNEIFORM 29 0.0048
176 DIABETIC RETINOPATHY 16 0.0047
177 VENTRICULAR ARRHYTHMIA 17 0.0046
178 BONE MARROW DISORDER 14 0.0046
179 RHINOVIRUS INFECTION 18 0.0046
180 PHOTOPSIA 29 0.0046
181 POLYDIPSIA 18 0.0045
182 MUSCLE CONTRACTIONS INVOLUNTARY 16 0.0045
183 CARDIAC ARREST 375 0.0045
184 BRAIN DEATH 14 0.0045
185 MYOCARDIAL ISCHAEMIA 51 0.0045
186 CARDIOMEGALY 55 0.0045
187 HYPOVOLAEMIA 26 0.0044
188 PERIORBITAL OEDEMA 23 0.0044
189 STRIDOR 13 0.0044
190 HYPOVOLAEMIC SHOCK 21 0.0044
191 INCOHERENT 28 0.0043
192 HYPOPNOEA 15 0.0043
193 PHOTOPHOBIA 81 0.0043
194 DYSARTHRIA 162 0.0043
195 MOUTH ULCERATION 90 0.0043
196 DEAFNESS NEUROSENSORY 14 0.0043
197 VISUAL ACUITY REDUCED 141 0.0042
198 SNORING 16 0.0042
199 AORTIC VALVE INCOMPETENCE 18 0.0042
200 TORSADE DE POINTES 33 0.0042
201 FAECALOMA 23 0.0042
202 HYPOTHERMIA 42 0.0041
203 BLINDNESS UNILATERAL 58 0.0041
204 ASPIRATION 45 0.0041
205 UNRESPONSIVE TO STIMULI 106 0.0041
206 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
207 POST PROCEDURAL COMPLICATION 76 0.0040
208 MACULOPATHY 14 0.0039
209 ILEUS 49 0.0039
210 FEBRILE NEUTROPENIA 261 0.0039
211 ANAPHYLACTOID REACTION 16 0.0039
212 MULTI-ORGAN FAILURE 67 0.0039
213 HYPERNATRAEMIA 19 0.0038
214 BLEPHAROSPASM 24 0.0038
215 CATATONIA 20 0.0038
216 PROCEDURAL COMPLICATION 29 0.0038
217 IRON DEFICIENCY 17 0.0038
218 PRODUCT LABEL CONFUSION 22 0.0038
219 ARTERIOSCLEROSIS CORONARY ARTERY 25 0.0038
220 RESPIRATION ABNORMAL 26 0.0038
221 ECONOMIC PROBLEM 57 0.0038
222 POOR PERIPHERAL CIRCULATION 16 0.0038
223 TACHYPNOEA 51 0.0037
224 GASTROINTESTINAL MOTILITY DISORDER 20 0.0037
225 TACHYCARDIA 331 0.0037
226 EYE PAIN 210 0.0037
227 OLIGURIA 23 0.0037
228 HYPOXIA 130 0.0037
229 BLOOD PRESSURE DIASTOLIC INCREASED 17 0.0037
230 MENTAL STATUS CHANGES 102 0.0037
231 PARTIAL SEIZURES 19 0.0036
232 NEUROLEPTIC MALIGNANT SYNDROME 43 0.0036
233 DRUG TOXICITY 49 0.0036
234 MUSCLE RIGIDITY 43 0.0036
235 ORAL PAIN 80 0.0036
236 ELECTROCARDIOGRAM ABNORMAL 28 0.0036
237 CARDIOMYOPATHY 52 0.0035
238 DELIRIUM 122 0.0035
239 CLOSTRIDIUM DIFFICILE COLITIS 37 0.0035
240 PNEUMONIA ASPIRATION 87 0.0035
241 CARDIO-RESPIRATORY ARREST 145 0.0035
242 FAILURE TO THRIVE 18 0.0035
243 HORDEOLUM 15 0.0035
244 LARGE INTESTINE PERFORATION 24 0.0035
245 CARDIAC FAILURE ACUTE 23 0.0034
246 NEUTROPHIL COUNT INCREASED 35 0.0034
247 ORAL CANDIDIASIS 45 0.0034
248 TONGUE OEDEMA 13 0.0034
249 ACIDOSIS 26 0.0034
250 DEPRESSED LEVEL OF CONSCIOUSNESS 134 0.0034
251 CARDIOPULMONARY FAILURE 13 0.0033
252 MYOCARDITIS 38 0.0033
253 SPINAL OSTEOARTHRITIS 29 0.0033
254 ENTEROCOLITIS 19 0.0033
255 HYPOTENSION 660 0.0033
256 INTESTINAL ISCHAEMIA 18 0.0033
257 SHOCK 75 0.0033
258 BODY TEMPERATURE DECREASED 32 0.0032
259 BREATH SOUNDS ABNORMAL 16 0.0032
260 ANAPHYLACTIC SHOCK 83 0.0032
261 MUCOSAL INFLAMMATION 84 0.0032
262 URINARY RETENTION 107 0.0032
263 OCULAR DISCOMFORT 36 0.0032
264 ARTERIOSCLEROSIS 30 0.0032
265 DROOLING 22 0.0032
266 HYPERLIPIDAEMIA 38 0.0032
267 BRONCHOSPASM 45 0.0032
268 FAECAL INCONTINENCE 15 0.0031
269 RENAL FAILURE CHRONIC 24 0.0031
270 CYANOSIS 49 0.0031
271 CIRCULATORY COLLAPSE 53 0.0031
272 RESPIRATORY FAILURE 224 0.0031
273 MULTIPLE USE OF SINGLE-USE PRODUCT 17 0.0030
274 OBSESSIVE-COMPULSIVE DISORDER 24 0.0030
275 SEPTIC SHOCK 129 0.0030
276 NEUTROPENIC SEPSIS 21 0.0029
277 RALES 17 0.0029
278 CACHEXIA 15 0.0029
279 TENDON DISORDER 19 0.0029
280 PARAESTHESIA ORAL 42 0.0029
281 GLAUCOMA 56 0.0029
282 GENERALISED TONIC-CLONIC SEIZURE 48 0.0029
283 COMA 138 0.0029
284 NEUROPATHY PERIPHERAL 275 0.0029
285 HALLUCINATION, VISUAL 61 0.0029
286 VISION BLURRED 395 0.0029
287 RESPIRATORY DISTRESS 79 0.0029
288 ISCHAEMIA 13 0.0028
289 BLINDNESS 115 0.0028
290 METABOLIC ACIDOSIS 90 0.0028
291 PULMONARY OEDEMA 126 0.0028
292 OXYGEN SATURATION DECREASED 158 0.0028
293 HYPOTONIA 28 0.0028
294 SCHIZOPHRENIA 34 0.0028
295 VAGINAL DISCHARGE 28 0.0028
296 LARYNGEAL OEDEMA 17 0.0028
297 HYPERCALCAEMIA 34 0.0028
298 HYDROCEPHALUS 15 0.0028
299 MIOSIS 22 0.0027
300 PHLEBITIS 14 0.0027
301 SARS-COV-2 TEST POSITIVE 36 0.0027
302 LUNG INFILTRATION 24 0.0027
303 PNEUMOTHORAX 43 0.0027
304 DECUBITUS ULCER 22 0.0027
305 FOETAL DEATH 14 0.0027
306 RENAL INJURY 80 0.0027
307 THERAPY INTERRUPTED 191 0.0027
308 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 146 0.0027
309 HEMIPARESIS 45 0.0027
310 ENTERITIS 17 0.0027
311 VENOOCCLUSIVE LIVER DISEASE 13 0.0026
312 TONGUE DISORDER 19 0.0026
313 RENAL FAILURE ACUTE 111 0.0026
314 SMALL INTESTINAL OBSTRUCTION 32 0.0026
315 BEHAVIOUR DISORDER 14 0.0026
316 METABOLIC DISORDER 15 0.0026
317 HALLUCINATION, AUDITORY 41 0.0026
318 HYPOALBUMINAEMIA 20 0.0026
319 COLITIS 97 0.0026
320 METASTASES TO CENTRAL NERVOUS SYSTEM 33 0.0026
321 DISORIENTATION 101 0.0025
322 ASTHENOPIA 14 0.0025
323 RHABDOMYOLYSIS 106 0.0025
324 INTESTINAL OBSTRUCTION 95 0.0025
325 BENIGN PROSTATIC HYPERPLASIA 13 0.0025
326 WRONG PRODUCT ADMINISTERED 17 0.0025
327 THERAPY CESSATION 129 0.0025
328 BLOOD UREA INCREASED 42 0.0025
329 EYE DISORDER 82 0.0025
330 BRAIN FOG 39 0.0025
331 COAGULOPATHY 41 0.0025
332 FLANK PAIN 23 0.0025
333 HEART RATE DECREASED 86 0.0024
334 PULMONARY HYPERTENSION 51 0.0024
335 BACTERAEMIA 29 0.0024
336 MYOCLONUS 29 0.0024
337 HALLUCINATION 183 0.0024
338 HYPERTENSIVE CRISIS 27 0.0024
339 SCOLIOSIS 15 0.0024
340 APHASIA 73 0.0024
341 DISSEMINATED INTRAVASCULAR COAGULATION 34 0.0024
342 BLOOD ALBUMIN DECREASED 19 0.0024
343 HIATUS HERNIA 31 0.0024
344 URINE ODOUR ABNORMAL 14 0.0024
345 FEAR 64 0.0024
346 HYPOMAGNESAEMIA 33 0.0024
347 HYPERKALAEMIA 83 0.0024
348 RESPIRATORY ARREST 65 0.0024
349 EYE MOVEMENT DISORDER 16 0.0023
350 THERAPY NON-RESPONDER 105 0.0023
351 HOSPICE CARE 23 0.0023
352 DYSPHONIA 136 0.0023
353 MALNUTRITION 26 0.0023
354 POLYURIA 19 0.0023
355 LYMPHOCYTE COUNT DECREASED 41 0.0023
356 HYPOKALAEMIA 107 0.0023
357 BLADDER DISORDER 23 0.0023
358 HICCUPS 19 0.0023
359 TOXICITY TO VARIOUS AGENTS 390 0.0023
360 DRUG INTERACTION 366 0.0023
361 OSTEOPENIA 35 0.0023
362 PARALYSIS 33 0.0023
363 SWOLLEN TONGUE 72 0.0023
364 END STAGE RENAL DISEASE 42 0.0023
365 MUSCLE INJURY 19 0.0023
366 URINE OUTPUT DECREASED 20 0.0023
367 AGITATION 168 0.0023
368 DRY MOUTH 185 0.0023
369 PIGMENTATION DISORDER 14 0.0023
370 EYELID PTOSIS 23 0.0023
371 DIVERTICULUM 16 0.0022
372 TOXIC EPIDERMAL NECROLYSIS 34 0.0022
373 HYPONATRAEMIA 126 0.0022
374 DRUG LEVEL INCREASED 37 0.0022
375 PLEURAL EFFUSION 136 0.0022
376 HYPOPHAGIA 57 0.0022
377 VISUAL FIELD DEFECT 16 0.0022
378 COGNITIVE DISORDER 103 0.0022
379 RETCHING 47 0.0022
380 FOREIGN BODY SENSATION IN EYES 14 0.0022
381 EXOSTOSIS 20 0.0022
382 PULMONARY HAEMORRHAGE 17 0.0022
383 CATARACT 129 0.0022
384 PRODUCT ADMINISTRATION INTERRUPTED 17 0.0022
385 GANGRENE 13 0.0022
386 EUPHORIC MOOD 22 0.0021
387 DEVICE RELATED INFECTION 33 0.0021
388 CONFUSIONAL STATE 346 0.0021
389 GINGIVAL PAIN 17 0.0021
390 ANAPHYLACTIC REACTION 118 0.0021
391 ANHEDONIA 56 0.0021
392 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 111 0.0021
393 PULMONARY CONGESTION 28 0.0021
394 WALKING AID USER 14 0.0021
395 BALANCE DISORDER 183 0.0021
396 HYPOCALCAEMIA 40 0.0021
397 OESOPHAGITIS 23 0.0021
398 PSEUDOMONAS INFECTION 18 0.0021
399 CHOLANGITIS 13 0.0021
400 ARRHYTHMIA 99 0.0021
401 PERICARDIAL EFFUSION 48 0.0021
402 RECTAL HAEMORRHAGE 89 0.0021
403 NERVE INJURY 23 0.0021
404 OBSTRUCTIVE AIRWAYS DISORDER 23 0.0021
405 INFUSION SITE SWELLING 13 0.0021
406 PSYCHOTIC DISORDER 61 0.0021
407 VITAMIN D DEFICIENCY 20 0.0020
408 SCAR 35 0.0020
409 ATRIAL FIBRILLATION 199 0.0020
410 ASCITES 60 0.0020
411 DIPLOPIA 53 0.0020
412 BLOOD TRIGLYCERIDES INCREASED 36 0.0020
413 STATUS EPILEPTICUS 23 0.0020
414 ACUTE RESPIRATORY DISTRESS SYNDROME 36 0.0020
415 BLOOD PRESSURE DIASTOLIC DECREASED 15 0.0020
416 THROMBOCYTOPENIA 227 0.0020
417 RENAL FAILURE 269 0.0020
418 PALLOR 55 0.0020
419 RENAL CYST 16 0.0020
420 EXTRASYSTOLES 14 0.0020
421 POISONING DELIBERATE 19 0.0020
422 DEMENTIA 56 0.0020
423 DEHYDRATION 267 0.0020
424 DELUSION 31 0.0020
425 DYSKINESIA 81 0.0020
426 ANGIOEDEMA 88 0.0020
427 BLOOD PRESSURE DECREASED 132 0.0020
428 EMPHYSEMA 20 0.0020
429 BLOOD CREATINE PHOSPHOKINASE INCREASED 57 0.0020
430 BRAIN OEDEMA 25 0.0020
431 ELECTROCARDIOGRAM QT PROLONGED 71 0.0020
432 NO THERAPEUTIC RESPONSE 24 0.0020
433 UPPER GASTROINTESTINAL HAEMORRHAGE 33 0.0020
434 ENCEPHALOPATHY 48 0.0020
435 IRON DEFICIENCY ANAEMIA 18 0.0019
436 EYE HAEMORRHAGE 26 0.0019
437 HEART RATE IRREGULAR 44 0.0019
438 FOOD ALLERGY 15 0.0019
439 ANKLE FRACTURE 30 0.0019
440 LEUKOCYTOSIS 35 0.0019
441 TUMOUR LYSIS SYNDROME 17 0.0019
442 EJECTION FRACTION DECREASED 30 0.0019
443 HAEMATURIA 66 0.0019
444 OCULAR HYPERAEMIA 91 0.0019
445 VISUAL IMPAIRMENT 237 0.0019
446 TRANSFUSION 20 0.0019
447 MUSCLE TWITCHING 44 0.0019
448 SEASONAL ALLERGY 27 0.0019
449 AKATHISIA 26 0.0019
450 NEURALGIA 46 0.0019
451 SUDDEN DEATH 20 0.0019
452 CONSTIPATION 412 0.0019
453 CONJUNCTIVITIS 35 0.0019
454 SEROTONIN SYNDROME 36 0.0019
455 RESPIRATORY DISORDER 56 0.0019
456 DYSPHAGIA 176 0.0019
457 HAEMORRHOIDS 36 0.0018
458 HYPERGLYCAEMIA 67 0.0018
459 COELIAC DISEASE 18 0.0018
460 RENAL TUBULAR NECROSIS 18 0.0018
461 HEPATOCELLULAR INJURY 26 0.0018
462 HYPERTENSION 388 0.0018
463 HEPATIC STEATOSIS 34 0.0018
464 NEUTROPENIA 248 0.0018
465 PREMATURE DELIVERY 29 0.0018
466 PRODUCT SUPPLY ISSUE 13 0.0018
467 INJURY 128 0.0018
468 PETECHIAE 19 0.0018
469 METASTASES TO LUNG 21 0.0018
470 WEIGHT FLUCTUATION 19 0.0018
471 HAEMOLYSIS 14 0.0018
472 ACUTE KIDNEY INJURY 277 0.0018
473 FOOT DEFORMITY 20 0.0018
474 BLOOD SODIUM DECREASED 34 0.0018
475 STEVENS-JOHNSON SYNDROME 40 0.0018
476 ACUTE MYOCARDIAL INFARCTION 53 0.0018
477 FOOT FRACTURE 34 0.0018
478 COORDINATION ABNORMAL 25 0.0018
479 SEIZURE 207 0.0018
480 PROTEINURIA 34 0.0018
481 SURGERY 104 0.0018
482 EYE INFECTION 20 0.0018
483 HYPERCHOLESTEROLAEMIA 17 0.0018
484 LACTIC ACIDOSIS 57 0.0018
485 FACIAL PARALYSIS 15 0.0018
486 ALTERED STATE OF CONSCIOUSNESS 38 0.0018
487 EMOTIONAL DISORDER 54 0.0017
488 PERIPHERAL COLDNESS 24 0.0017
489 PARANOIA 30 0.0017
490 ISCHAEMIC STROKE 31 0.0017
491 INFUSION RELATED REACTION 115 0.0017
492 GRAND MAL CONVULSION 16 0.0017
493 HYSTERECTOMY 15 0.0017
494 INTERVERTEBRAL DISC DEGENERATION 16 0.0017
495 ELECTROLYTE IMBALANCE 20 0.0017
496 HAEMATOCHEZIA 95 0.0017
497 HAEMATOCRIT DECREASED 34 0.0017
498 SPLENOMEGALY 20 0.0017
499 METASTASES TO BONE 28 0.0017
500 ABSCESS 27 0.0017
501 ACUTE CORONARY SYNDROME 14 0.0017
502 EYE IRRITATION 97 0.0017
503 DISEASE PROGRESSION 199 0.0017
504 THIRST 30 0.0017
505 SECRETION DISCHARGE 21 0.0017
506 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 13 0.0017
507 MOBILITY DECREASED 119 0.0017
508 HYPERHIDROSIS 212 0.0016
509 FREQUENT BOWEL MOVEMENTS 44 0.0016
510 CARDIAC OPERATION 14 0.0016
511 ANURIA 14 0.0016
512 UROSEPSIS 15 0.0016
513 PNEUMONITIS 44 0.0016
514 GENERALISED OEDEMA 20 0.0016
515 IMMUNODEFICIENCY 24 0.0016
516 APPLICATION SITE IRRITATION 20 0.0016
517 DYSURIA 59 0.0016
518 UPPER RESPIRATORY TRACT INFECTION 74 0.0016
519 NEUROTOXICITY 28 0.0016
520 SWELLING FACE 104 0.0016
521 SHOCK HAEMORRHAGIC 13 0.0016
522 CHOLECYSTITIS 19 0.0016
523 CHOKING 31 0.0016
524 PULMONARY EMBOLISM 151 0.0016
525 COLD SWEAT 28 0.0016
526 TOXIC SKIN ERUPTION 16 0.0016
527 SPUTUM DISCOLOURED 15 0.0016
528 DYSPNOEA 895 0.0016
529 HAEMATEMESIS 40 0.0016
530 SPINAL COMPRESSION FRACTURE 13 0.0016
531 LOSS OF CONSCIOUSNESS 201 0.0016
532 GALLBLADDER DISORDER 28 0.0016
533 CEREBRAL INFARCTION 38 0.0016
534 CHRONIC KIDNEY DISEASE 118 0.0016
535 MUSCLE SPASTICITY 19 0.0015
536 CYTOKINE RELEASE SYNDROME 31 0.0015
537 VOMITING 724 0.0015
538 EYE DISCHARGE 16 0.0015
539 SEPSIS 171 0.0015
540 PRODUCTIVE COUGH 73 0.0015
541 SPEECH DISORDER 80 0.0015
542 HEPATOMEGALY 15 0.0015
543 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 26 0.0015
544 BLOOD LACTATE DEHYDROGENASE INCREASED 24 0.0015
545 GENERAL PHYSICAL HEALTH DETERIORATION 175 0.0015
546 OBESITY 24 0.0015
547 HEART RATE INCREASED 149 0.0015
548 CARDIAC MURMUR 13 0.0015
549 APPENDICITIS 14 0.0015
550 DEFORMITY 14 0.0015
551 ABDOMINAL PAIN 348 0.0015
552 DEEP VEIN THROMBOSIS 97 0.0015
553 CORONARY ARTERY DISEASE 45 0.0015
554 PANCYTOPENIA 83 0.0015
555 DRY EYE 74 0.0015
556 CANDIDA INFECTION 25 0.0015
557 MOTOR DYSFUNCTION 15 0.0015
558 IMPAIRED GASTRIC EMPTYING 20 0.0015
559 SUBDURAL HAEMATOMA 21 0.0015
560 CHEST PAIN 271 0.0015
561 STOMATITIS 88 0.0014
562 ALANINE AMINOTRANSFERASE INCREASED 89 0.0014
563 RESTLESSNESS 53 0.0014
564 NEUTROPHIL COUNT DECREASED 59 0.0014
565 GAMMA-GLUTAMYLTRANSFERASE INCREASED 32 0.0014
566 OROPHARYNGEAL DISCOMFORT 13 0.0014
567 OEDEMA 78 0.0014
568 PRODUCT ADMINISTRATION ERROR 29 0.0014
569 DYSPNOEA EXERTIONAL 54 0.0014
570 BONE MARROW FAILURE 29 0.0014
571 FISTULA 16 0.0014
572 FALL 473 0.0014
573 PNEUMONIA 460 0.0014
574 URINARY INCONTINENCE 42 0.0014
575 NEPHROLITHIASIS 65 0.0014
576 EPISTAXIS 106 0.0014
577 PAIN IN JAW 40 0.0014
578 VERTIGO 86 0.0014
579 ANAEMIA 269 0.0014
580 PULMONARY MASS 21 0.0014
581 PYREXIA 484 0.0014
582 PRESYNCOPE 34 0.0014
583 BLOOD POTASSIUM DECREASED 42 0.0014
584 BRAIN INJURY 14 0.0014
585 BLOOD CREATININE INCREASED 91 0.0014
586 GINGIVAL BLEEDING 19 0.0014
587 OFF LABEL USE 1218 0.0014
588 INTENTIONAL OVERDOSE 89 0.0014
589 SPINAL OPERATION 17 0.0014
590 DRY THROAT 14 0.0014
591 DIARRHOEA 889 0.0014
592 C-REACTIVE PROTEIN INCREASED 50 0.0014
593 MUSCULAR WEAKNESS 156 0.0014
594 CHOLELITHIASIS 45 0.0014
595 BLOOD BILIRUBIN INCREASED 37 0.0014
596 BLOOD ALKALINE PHOSPHATASE INCREASED 34 0.0014
597 OSTEOARTHRITIS 58 0.0014
598 GASTRITIS 36 0.0014
599 ACCIDENTAL OVERDOSE 50 0.0014
600 WHEEZING 81 0.0014
601 METASTASES TO LIVER 24 0.0014
602 FACE OEDEMA 23 0.0014
603 SLEEP APNOEA SYNDROME 26 0.0014
604 LEUKOPENIA 68 0.0014
605 NAUSEA 1075 0.0014
606 CARDIAC FAILURE CONGESTIVE 109 0.0014
607 CHOLESTASIS 26 0.0014
608 RASH MACULO-PAPULAR 30 0.0013
609 ATAXIA 16 0.0013
610 CARDIAC FAILURE 108 0.0013
611 PRESCRIBED OVERDOSE 26 0.0013
612 MULTIPLE ORGAN DYSFUNCTION SYNDROME 38 0.0013
613 EYE PRURITUS 45 0.0013
614 DECREASED APPETITE 311 0.0013
615 LETHARGY 77 0.0013
616 HAEMORRHAGE INTRACRANIAL 20 0.0013
617 ASPARTATE AMINOTRANSFERASE INCREASED 71 0.0013
618 INTESTINAL PERFORATION 15 0.0013
619 SOMNOLENCE 269 0.0013
620 PROCEDURAL PAIN 37 0.0013
621 PARKINSONISM 13 0.0013
622 WHITE BLOOD CELL COUNT INCREASED 51 0.0013
623 HYPOAESTHESIA ORAL 20 0.0013
624 URINARY TRACT INFECTION 226 0.0013
625 HAEMOGLOBIN DECREASED 136 0.0013
626 KNEE OPERATION 13 0.0013
627 INFUSION SITE PAIN 17 0.0013
628 CHEST DISCOMFORT 135 0.0013
629 NERVOUS SYSTEM DISORDER 41 0.0013
630 PANCREATITIS 69 0.0013
631 SYNCOPE 130 0.0013
632 RENAL IMPAIRMENT 109 0.0013
633 HEAD INJURY 41 0.0013
634 CELLULITIS 65 0.0013
635 PHARYNGITIS 16 0.0013
636 MENTAL DISORDER 56 0.0013
637 EAR PAIN 25 0.0013
638 DRUG ABUSE 107 0.0013
639 LOCALISED INFECTION 31 0.0013
640 OEDEMA PERIPHERAL 156 0.0013
641 SKIN ULCER 33 0.0013
642 COLON CANCER 19 0.0013
643 BODY TEMPERATURE INCREASED 26 0.0013
644 LIVER FUNCTION TEST ABNORMAL 37 0.0013
645 PRODUCT USE COMPLAINT 20 0.0013
646 GASTROINTESTINAL HAEMORRHAGE 106 0.0013
647 RESPIRATORY TRACT INFECTION 33 0.0013
648 FUNGAL INFECTION 42 0.0013
649 CEREBRAL HAEMORRHAGE 45 0.0013
650 EOSINOPHILIA 22 0.0013
651 HAEMOPTYSIS 35 0.0013
652 TENDERNESS 13 0.0012
653 DEATH 1069 0.0012
654 RHINORRHOEA 80 0.0012
655 AGRANULOCYTOSIS 23 0.0012
656 INFECTION 179 0.0012
657 EYE SWELLING 46 0.0012
658 BURSITIS 15 0.0012
659 TASTE DISORDER 25 0.0012
660 BLOOD PRESSURE SYSTOLIC INCREASED 24 0.0012
661 TREMOR 204 0.0012
662 MELAENA 27 0.0012
663 CONTUSION 118 0.0012
664 HYPERSOMNIA 35 0.0012
665 INFLAMMATION 63 0.0012
666 BEDRIDDEN 16 0.0012
667 MASS 17 0.0012
668 OVERDOSE 261 0.0012
669 MADAROSIS 14 0.0012
670 EYELID OEDEMA 14 0.0012
671 POST PROCEDURAL HAEMORRHAGE 14 0.0012
672 PLATELET COUNT DECREASED 128 0.0012
673 PULMONARY FIBROSIS 23 0.0012
674 DIALYSIS 17 0.0012
675 RESPIRATORY TRACT CONGESTION 19 0.0012
676 INTENTIONAL DOSE OMISSION 34 0.0012
677 LACRIMATION INCREASED 36 0.0012
678 OSTEOPOROSIS 49 0.0012
679 HYPOTHYROIDISM 38 0.0012
680 ANXIETY 338 0.0012
681 IMPAIRED QUALITY OF LIFE 17 0.0012
682 ORAL HERPES 23 0.0012
683 COUGH 330 0.0012
684 PRODUCT USE IN UNAPPROVED INDICATION 291 0.0012
685 EATING DISORDER 25 0.0012
686 PULMONARY ARTERIAL HYPERTENSION 17 0.0012
687 BLOOD POTASSIUM INCREASED 19 0.0012
688 DYSPEPSIA 115 0.0012
689 ILL-DEFINED DISORDER 71 0.0012
690 HEPATOTOXICITY 26 0.0012
691 GASTROENTERITIS 17 0.0012
692 SINUS DISORDER 23 0.0012
693 FLUID RETENTION 59 0.0012
694 PERITONITIS 24 0.0012
695 BLOOD PRESSURE ABNORMAL 23 0.0012
696 MANIA 19 0.0012
697 CONVULSION 66 0.0012
698 THERAPY PARTIAL RESPONDER 18 0.0012
699 BONE DISORDER 21 0.0012
700 MOVEMENT DISORDER 37 0.0012
701 APHONIA 16 0.0011
702 DERMATITIS CONTACT 13 0.0011
703 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
704 DYSTONIA 22 0.0011
705 HOSPITALISATION 174 0.0011
706 EXTRAPYRAMIDAL DISORDER 28 0.0011
707 FATIGUE 877 0.0011
708 CONDITION AGGRAVATED 342 0.0011
709 ABDOMINAL DISTENSION 117 0.0011
710 HAEMATOMA 29 0.0011
711 RIB FRACTURE 23 0.0011
712 JAUNDICE 30 0.0011
713 ASTHENIA 419 0.0011
714 VIRAL INFECTION 37 0.0011
715 HYPERSENSITIVITY 206 0.0011
716 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
717 UNEVALUABLE EVENT 83 0.0011
718 WEIGHT DECREASED 306 0.0011
719 PAIN 671 0.0011
720 CENTRAL NERVOUS SYSTEM LESION 15 0.0011
721 APPLICATION SITE RASH 15 0.0011
722 ANOREXIA 14 0.0011
723 RED BLOOD CELL COUNT DECREASED 31 0.0011
724 PSORIATIC ARTHROPATHY 44 0.0011
725 DRUG INTOLERANCE 104 0.0011
726 PLATELET COUNT INCREASED 14 0.0011
727 THROAT TIGHTNESS 29 0.0011
728 ERYTHEMA 220 0.0011
729 THROAT IRRITATION 48 0.0011
730 ABDOMINAL PAIN LOWER 27 0.0011
731 DIZZINESS 531 0.0011
732 BLOOD PRESSURE INCREASED 162 0.0011
733 HEADACHE 650 0.0010
734 FEEDING DISORDER 21 0.0010
735 POISONING 13 0.0010
736 FLUSHING 105 0.0010
737 LUNG INFECTION 16 0.0010
738 COLITIS ULCERATIVE 46 0.0010
739 BRONCHITIS 76 0.0010
740 MUSCLE ATROPHY 13 0.0010
741 WHITE BLOOD CELL COUNT DECREASED 111 0.0010
742 CONTRAINDICATED PRODUCT ADMINISTERED 31 0.0010
743 POOR QUALITY SLEEP 22 0.0010
744 LUNG DISORDER 50 0.0010
745 GASTROOESOPHAGEAL REFLUX DISEASE 82 0.0010
746 BACK PAIN 235 0.0010
747 SUICIDE ATTEMPT 61 0.0010
748 MATERNAL EXPOSURE DURING PREGNANCY 89 0.0010
749 SYNOVITIS 18 0.0010
750 NODULE 13 0.0010
751 DEVICE OCCLUSION 14 0.0010
752 HAEMORRHAGE 104 0.0010
753 HEPATIC FUNCTION ABNORMAL 37 0.0010
754 SKIN DISORDER 33 0.0010
755 GAIT DISTURBANCE 189 0.0010
756 EPILEPSY 30 0.0010
757 TYPE 2 DIABETES MELLITUS 33 0.0010
758 TRANSIENT ISCHAEMIC ATTACK 33 0.0010
759 CYSTITIS 31 0.0010
760 PARAESTHESIA 153 0.0010
761 ABASIA 24 0.0010
762 STAPHYLOCOCCAL INFECTION 32 0.0010
763 MUSCULOSKELETAL CHEST PAIN 15 0.0010
764 HYPOGLYCAEMIA 47 0.0010
765 EMOTIONAL DISTRESS 117 0.0010
766 SINUS CONGESTION 13 0.0010
767 FLUID OVERLOAD 14 0.0010
768 HEPATIC FAILURE 29 0.0010
769 OROPHARYNGEAL PAIN 89 0.0010
770 POLLAKIURIA 40 0.0010
771 WITHDRAWAL SYNDROME 40 0.0010
772 INTERNATIONAL NORMALISED RATIO INCREASED 27 0.0009
773 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 22 0.0009
774 BLISTER 53 0.0009
775 SCIATICA 15 0.0009
776 EAR INFECTION 25 0.0009
777 HIP FRACTURE 30 0.0009
778 PREMATURE BABY 28 0.0009
779 AGEUSIA 23 0.0009
780 RASH ERYTHEMATOUS 44 0.0009
781 ABNORMAL BEHAVIOUR 36 0.0009
782 AMNESIA 59 0.0009
783 SLEEP DISORDER 64 0.0009
784 PALPITATIONS 106 0.0009
785 DIABETES MELLITUS INADEQUATE CONTROL 16 0.0009
786 ACUTE MYELOID LEUKAEMIA 14 0.0009
787 BASAL CELL CARCINOMA 14 0.0009
788 HYPOKINESIA 13 0.0009
789 DRUG RESISTANCE 23 0.0009
790 DIABETES MELLITUS 68 0.0009
791 MALIGNANT NEOPLASM PROGRESSION 91 0.0009
792 RASH MACULAR 31 0.0009
793 GASTROENTERITIS VIRAL 16 0.0009
794 CHROMATURIA 20 0.0009
795 OSTEOMYELITIS 16 0.0009
796 APPLICATION SITE ERYTHEMA 23 0.0009
797 TREATMENT NONCOMPLIANCE 48 0.0009
798 LIMB DISCOMFORT 27 0.0009
799 ANGINA PECTORIS 25 0.0009
800 PRODUCT PRESCRIBING ISSUE 19 0.0009
801 EXPOSURE DURING PREGNANCY 54 0.0009
802 MALAISE 380 0.0009
803 KIDNEY INFECTION 17 0.0009
804 NEOPLASM PROGRESSION 30 0.0009
805 APPLICATION SITE PAIN 19 0.0009
806 HEPATITIS 22 0.0009
807 DISABILITY 17 0.0009
808 BACTERIAL INFECTION 16 0.0009
809 TUBULOINTERSTITIAL NEPHRITIS 16 0.0009
810 PHARYNGEAL OEDEMA 13 0.0008
811 CHILLS 99 0.0008
812 BLOOD URINE PRESENT 16 0.0008
813 APPLICATION SITE PRURITUS 19 0.0008
814 ROAD TRAFFIC ACCIDENT 35 0.0008
815 DISTURBANCE IN ATTENTION 45 0.0008
816 MEDICATION ERROR 46 0.0008
817 LUNG NEOPLASM MALIGNANT 34 0.0008
818 TINNITUS 38 0.0008
819 MENTAL IMPAIRMENT 20 0.0008
820 RESTLESS LEGS SYNDROME 15 0.0008
821 THROMBOSIS 66 0.0008
822 SINUSITIS 84 0.0008
823 LOWER RESPIRATORY TRACT INFECTION 37 0.0008
824 CARDIAC DISORDER 76 0.0008
825 SENSORY DISTURBANCE 13 0.0008
826 ARTHROPATHY 45 0.0008
827 TRANSAMINASES INCREASED 18 0.0008
828 OSTEONECROSIS OF JAW 20 0.0008
829 GASTROINTESTINAL DISORDER 72 0.0008
830 UPPER LIMB FRACTURE 16 0.0008
831 CEREBROVASCULAR ACCIDENT 136 0.0008
832 HEPATIC CIRRHOSIS 15 0.0008
833 PANIC ATTACK 29 0.0008
834 PLASMA CELL MYELOMA 31 0.0008
835 RENAL DISORDER 37 0.0008
836 PRODUCT AVAILABILITY ISSUE 18 0.0008
837 DRUG INEFFECTIVE 1041 0.0008
838 PHOTOSENSITIVITY REACTION 13 0.0008
839 ILLNESS 81 0.0008
840 PRURITUS GENERALISED 17 0.0008
841 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 158 0.0008
842 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
843 GAIT INABILITY 26 0.0008
844 TOOTHACHE 14 0.0008
845 DISCOMFORT 47 0.0008
846 ASTHMA 87 0.0008
847 MUSCLE SPASMS 141 0.0008
848 PERIPHERAL SWELLING 118 0.0008
849 MEMORY IMPAIRMENT 105 0.0008
850 INFLUENZA 85 0.0008
851 KNEE ARTHROPLASTY 16 0.0008
852 COVID-19 133 0.0008
853 DYSGEUSIA 56 0.0008
854 BLOOD PRESSURE FLUCTUATION 18 0.0007
855 CARDIOVASCULAR DISORDER 19 0.0007
856 IRRITABLE BOWEL SYNDROME 16 0.0007
857 FULL BLOOD COUNT DECREASED 15 0.0007
858 SKIN CANCER 16 0.0007
859 HYPOAESTHESIA 111 0.0007
860 ARTHRITIS 58 0.0007
861 LYMPHADENOPATHY 26 0.0007
862 ABDOMINAL PAIN UPPER 150 0.0007
863 RASH 317 0.0007
864 TOOTH LOSS 15 0.0007
865 NEEDLE ISSUE 21 0.0007
866 DYSSTASIA 21 0.0007
867 NECK PAIN 40 0.0007
868 GLYCOSYLATED HAEMOGLOBIN INCREASED 18 0.0007
869 WEIGHT INCREASED 159 0.0007
870 HEPATIC ENZYME INCREASED 48 0.0007
871 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 18 0.0007
872 MYOCARDIAL INFARCTION 122 0.0007
873 LIVER FUNCTION TEST INCREASED 15 0.0007
874 MIDDLE INSOMNIA 13 0.0007
875 INSOMNIA 185 0.0007
876 INTENTIONAL SELF-INJURY 14 0.0007
877 SKIN LESION 19 0.0007
878 PAIN IN EXTREMITY 204 0.0007
879 FAECES DISCOLOURED 15 0.0007
880 WOUND 19 0.0007
881 LOWER LIMB FRACTURE 13 0.0007
882 LIVER DISORDER 30 0.0007
883 TARDIVE DYSKINESIA 19 0.0007
884 HERNIA 13 0.0007
885 PANCREATITIS ACUTE 15 0.0007
886 SWELLING 62 0.0007
887 HERPES ZOSTER 38 0.0007
888 DEPRESSION 150 0.0007
889 ACTIVITIES OF DAILY LIVING IMPAIRED 13 0.0007
890 JOINT INJURY 14 0.0007
891 PRODUCT QUALITY ISSUE 89 0.0007
892 FEELING ABNORMAL 157 0.0007
893 SKIN DISCOLOURATION 30 0.0007
894 ANGER 22 0.0006
895 DEAFNESS 17 0.0006
896 MUSCULOSKELETAL PAIN 34 0.0006
897 THERAPEUTIC RESPONSE UNEXPECTED 29 0.0006
898 FOETAL EXPOSURE DURING PREGNANCY 52 0.0006
899 INTENTIONAL PRODUCT USE ISSUE 56 0.0006
900 FEELING HOT 39 0.0006
901 PRODUCT USE ISSUE 119 0.0006
902 CRYING 23 0.0006
903 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 45 0.0006
904 IRRITABILITY 38 0.0006
905 PRODUCT PRESCRIBING ERROR 15 0.0006
906 NASAL CONGESTION 37 0.0006
907 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 30 0.0006
908 SNEEZING 14 0.0006
909 INTENTIONAL DRUG MISUSE 13 0.0006
910 JOINT SWELLING 75 0.0006
911 DRUG ADMINISTRATION ERROR 19 0.0006
912 MIGRAINE 58 0.0006
913 DRY SKIN 81 0.0006
914 BLOOD GLUCOSE DECREASED 29 0.0006
915 ARTHRALGIA 251 0.0006
916 AGGRESSION 30 0.0006
917 ALOPECIA 117 0.0006
918 ECZEMA 31 0.0006
919 ADVERSE DRUG REACTION 53 0.0006
920 NIGHT SWEATS 19 0.0006
921 PRURITUS 224 0.0006
922 GLOSSODYNIA 13 0.0006
923 BLOOD CHOLESTEROL INCREASED 27 0.0006
924 IMPAIRED HEALING 19 0.0006
925 NERVOUSNESS 30 0.0006
926 INTENTIONAL PRODUCT MISUSE 50 0.0006
927 LIVER INJURY 14 0.0006
928 DEPRESSED MOOD 30 0.0006
929 BURNING SENSATION 39 0.0006
930 URTICARIA 93 0.0006
931 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 100 0.0006
932 ABDOMINAL DISCOMFORT 93 0.0006
933 NEOPLASM MALIGNANT 37 0.0006
934 VAGINAL HAEMORRHAGE 24 0.0006
935 BONE PAIN 32 0.0005
936 SKIN EXFOLIATION 46 0.0005
937 SUICIDAL IDEATION 49 0.0005
938 HOT FLUSH 40 0.0005
939 PRODUCT DOSE OMISSION IN ERROR 15 0.0005
940 DISEASE RECURRENCE 25 0.0005
941 BLOOD GLUCOSE INCREASED 98 0.0005
942 MUSCULOSKELETAL STIFFNESS 45 0.0005
943 HYPOACUSIS 22 0.0005
944 DRUG-INDUCED LIVER INJURY 16 0.0005
945 LABORATORY TEST ABNORMAL 15 0.0005
946 PRODUCT DOSE OMISSION ISSUE 149 0.0005
947 FEELING COLD 14 0.0005
948 MYALGIA 85 0.0005
949 RASH PRURITIC 27 0.0005
950 WRONG TECHNIQUE IN DRUG USAGE PROCESS 18 0.0005
951 FLATULENCE 28 0.0005
952 COMPLETED SUICIDE 41 0.0005
953 INFLUENZA LIKE ILLNESS 40 0.0005
954 TREATMENT FAILURE 40 0.0005
955 LIP SWELLING 16 0.0005
956 INTERSTITIAL LUNG DISEASE 23 0.0005
957 DIVERTICULITIS 13 0.0005
958 NIGHTMARE 16 0.0005
959 PSORIASIS 60 0.0005
960 EXPIRED PRODUCT ADMINISTERED 15 0.0005
961 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 15 0.0004
962 NASOPHARYNGITIS 78 0.0004
963 BONE DENSITY DECREASED 13 0.0004
964 OSTEONECROSIS 13 0.0004
965 EXTRA DOSE ADMINISTERED 16 0.0004
966 INCORRECT DOSE ADMINISTERED 90 0.0004
967 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
968 INCORRECT ROUTE OF DRUG ADMINISTRATION 14 0.0004
969 GASTRIC DISORDER 13 0.0004
970 ACNE 28 0.0004
971 DEVICE LEAKAGE 16 0.0004
972 PRODUCT DOSE OMISSION 24 0.0004
973 THERAPEUTIC RESPONSE DECREASED 22 0.0004
974 DRUG WITHDRAWAL SYNDROME 30 0.0003
975 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
976 UNDERDOSE 24 0.0003
977 MULTIPLE SCLEROSIS RELAPSE 22 0.0003
978 ADVERSE EVENT 28 0.0003
979 DEVICE ISSUE 27 0.0003
980 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 14 0.0003
981 RHEUMATOID ARTHRITIS 34 0.0003
982 DEVICE DISLOCATION 13 0.0003
983 PRODUCT SUBSTITUTION ISSUE 17 0.0003
984 SKIN IRRITATION 13 0.0003
985 DEVICE MALFUNCTION 18 0.0003
986 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 18 0.0003
987 PRODUCT STORAGE ERROR 21 0.0002
988 INJECTION SITE PAIN 65 0.0002
989 NO ADVERSE EVENT 37 0.0002
990 PROSTATE CANCER 16 0.0002
991 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
992 DRUG DEPENDENCE 28 0.0002
993 BREAST CANCER 13 0.0001
994 INJECTION SITE ERYTHEMA 16 0.0001
995 DRUG DOSE OMISSION 18 0.0001